Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02804334 · ClinicalTrials.gov registry record
The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- 29
- Enrollment target
NCT02804334: Clinical Trial study, sponsored by University Hospitals Cleveland Medical Center.
NCT02804334 is a clinical trial that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02804334 was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The goal of this project is to study \~45 molecules in blood cells that may differentiate patients with bipolar disorder from healthy controls.
Interventions
- PROCEDURE Blood draw
- PROCEDURE Psychiatric Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-10 |
Why NCT02804334 stopped before completion
NCT02804334 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT02804334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02804334 about?
NCT02804334 is a clinical study titled "The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders". The goal of this project is to study \~45 molecules in blood cells that may differentiate patients with bipolar disorder from healthy controls.
What is the current status of trial NCT02804334?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2016-06. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02804334?
The interventions under investigation include: Blood draw (PROCEDURE), Psychiatric Questionnaires (PROCEDURE).
Who is sponsoring clinical trial NCT02804334?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia